Selected research
Industry Research
Pain Reliever Industry Research Report 2026
Market perspective
The global Pain Reliever market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pain Reliever is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pain Reliever is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pain Reliever is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pain Reliever include Teva, Sanofi, J&J, Merck, Eli Lilly, Pfizer, GSK, Bayer and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pain Reliever market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pain Reliever Market by Company
Teva
Sanofi
J&J
Merck
Eli Lilly
Pfizer
GSK
Bayer
AstraZeneca
Yunnan Baiyao
Purdue
Grunenthal
Endo
Depomed
Allergan
Pain Reliever Segment by Type
Branded Opioids
NSAIDs
Generic Opioids
Others
Pain Reliever Segment by Application
Hospitals
Clinics
Drugstores
Pain Reliever Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pain Reliever market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pain Reliever and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pain Reliever.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pain Reliever manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pain Reliever by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pain Reliever in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Branded Opioids
- NSAIDs
- Generic Opioids
- Others
Applications
- Hospitals
- Clinics
- Drugstores
Companies covered
- Teva
- Sanofi
- J&J
- Merck
- Eli Lilly
- Pfizer
- GSK
- Bayer
- AstraZeneca
- Yunnan Baiyao
- Purdue
- Grunenthal
- Endo
- Depomed
- Allergan
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pain Reliever Market Size (2021-2032)
- 2.2.2 Global Pain Reliever Sales (2021-2032)
- 2.2.3 Global Pain Reliever Market Average Price (2021-2032)
- 2.3 Pain Reliever by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Branded Opioids
- 2.3.3 NSAIDs
- 2.3.4 Generic Opioids
- 2.3.5 Others
- 2.4 Pain Reliever by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Clinics
- 2.4.4 Drugstores
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pain Reliever Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pain Reliever Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Pain Reliever Revenue of Manufacturers (2021-2026)
- 3.4 Global Pain Reliever Average Price by Manufacturers (2021-2026)
- 3.5 Global Pain Reliever Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pain Reliever, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pain Reliever, Product Type & Application
- 3.8 Global Manufacturers of Pain Reliever, Established Date
- 3.9 Global Pain Reliever Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva
- 4.1.1 Teva Company Information
- 4.1.2 Teva Business Overview
- 4.1.3 Teva Pain Reliever Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Pain Reliever Product Portfolio
- 4.1.5 Teva Recent Developments
- 4.2 Sanofi
- 4.2.1 Sanofi Company Information
- 4.2.2 Sanofi Business Overview
- 4.2.3 Sanofi Pain Reliever Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi Pain Reliever Product Portfolio
- 4.2.5 Sanofi Recent Developments
- 4.3 J&J
- 4.3.1 J&J Company Information
- 4.3.2 J&J Business Overview
- 4.3.3 J&J Pain Reliever Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 J&J Pain Reliever Product Portfolio
- 4.3.5 J&J Recent Developments
- 4.4 Merck
- 4.4.1 Merck Company Information
- 4.4.2 Merck Business Overview
- 4.4.3 Merck Pain Reliever Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Merck Pain Reliever Product Portfolio
- 4.4.5 Merck Recent Developments
- 4.5 Eli Lilly
- 4.5.1 Eli Lilly Company Information
- 4.5.2 Eli Lilly Business Overview
- 4.5.3 Eli Lilly Pain Reliever Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Eli Lilly Pain Reliever Product Portfolio
- 4.5.5 Eli Lilly Recent Developments
- 4.6 Pfizer
- 4.6.1 Pfizer Company Information
- 4.6.2 Pfizer Business Overview
- 4.6.3 Pfizer Pain Reliever Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pfizer Pain Reliever Product Portfolio
- 4.6.5 Pfizer Recent Developments
- 4.7 GSK
- 4.7.1 GSK Company Information
- 4.7.2 GSK Business Overview
- 4.7.3 GSK Pain Reliever Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 GSK Pain Reliever Product Portfolio
- 4.7.5 GSK Recent Developments
- 4.8 Bayer
- 4.8.1 Bayer Company Information
- 4.8.2 Bayer Business Overview
- 4.8.3 Bayer Pain Reliever Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Bayer Pain Reliever Product Portfolio
- 4.8.5 Bayer Recent Developments
- 4.9 AstraZeneca
- 4.9.1 AstraZeneca Company Information
- 4.9.2 AstraZeneca Business Overview
- 4.9.3 AstraZeneca Pain Reliever Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 AstraZeneca Pain Reliever Product Portfolio
- 4.9.5 AstraZeneca Recent Developments
- 4.10 Yunnan Baiyao
- 4.10.1 Yunnan Baiyao Company Information
- 4.10.2 Yunnan Baiyao Business Overview
- 4.10.3 Yunnan Baiyao Pain Reliever Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Yunnan Baiyao Pain Reliever Product Portfolio
- 4.10.5 Yunnan Baiyao Recent Developments
- 4.11 Purdue
- 4.11.1 Purdue Company Information
- 4.11.2 Purdue Business Overview
- 4.11.3 Purdue Pain Reliever Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Purdue Pain Reliever Product Portfolio
- 4.11.5 Purdue Recent Developments
- 4.12 Grunenthal
- 4.12.1 Grunenthal Company Information
- 4.12.2 Grunenthal Business Overview
- 4.12.3 Grunenthal Pain Reliever Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Grunenthal Pain Reliever Product Portfolio
- 4.12.5 Grunenthal Recent Developments
- 4.13 Endo
- 4.13.1 Endo Company Information
- 4.13.2 Endo Business Overview
- 4.13.3 Endo Pain Reliever Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Endo Pain Reliever Product Portfolio
- 4.13.5 Endo Recent Developments
- 4.14 Depomed
- 4.14.1 Depomed Company Information
- 4.14.2 Depomed Business Overview
- 4.14.3 Depomed Pain Reliever Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Depomed Pain Reliever Product Portfolio
- 4.14.5 Depomed Recent Developments
- 4.15 Allergan
- 4.15.1 Allergan Company Information
- 4.15.2 Allergan Business Overview
- 4.15.3 Allergan Pain Reliever Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Allergan Pain Reliever Product Portfolio
- 4.15.5 Allergan Recent Developments
5 Global Pain Reliever Market Scenario by Region
- 5.1 Global Pain Reliever Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pain Reliever Sales by Region: 2021-2032
- 5.2.1 Global Pain Reliever Sales by Region: 2021-2026
- 5.2.2 Global Pain Reliever Sales by Region: 2027-2032
- 5.3 Global Pain Reliever Revenue by Region: 2021-2032
- 5.3.1 Global Pain Reliever Revenue by Region: 2021-2026
- 5.3.2 Global Pain Reliever Revenue by Region: 2027-2032
- 5.4 North America Pain Reliever Market Facts & Figures by Country
- 5.4.1 North America Pain Reliever Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pain Reliever Sales by Country (2021-2032)
- 5.4.3 North America Pain Reliever Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Pain Reliever Market Facts & Figures by Country
- 5.5.1 Europe Pain Reliever Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pain Reliever Sales by Country (2021-2032)
- 5.5.3 Europe Pain Reliever Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Pain Reliever Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pain Reliever Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pain Reliever Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pain Reliever Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pain Reliever Market Facts & Figures by Country
- 5.7.1 South America Pain Reliever Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pain Reliever Sales by Country (2021-2032)
- 5.7.3 South America Pain Reliever Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Pain Reliever Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pain Reliever Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pain Reliever Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pain Reliever Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Pain Reliever Sales by Type (2021-2032)
- 6.1.1 Global Pain Reliever Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Pain Reliever Sales Market Share by Type (2021-2032)
- 6.2 Global Pain Reliever Revenue by Type (2021-2032)
- 6.2.1 Global Pain Reliever Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pain Reliever Revenue Market Share by Type (2021-2032)
- 6.3 Global Pain Reliever Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pain Reliever Sales by Application (2021-2032)
- 7.1.1 Global Pain Reliever Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Pain Reliever Sales Market Share by Application (2021-2032)
- 7.2 Global Pain Reliever Revenue by Application (2021-2032)
- 7.2.1 Global Pain Reliever Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pain Reliever Revenue Market Share by Application (2021-2032)
- 7.3 Global Pain Reliever Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pain Reliever Value Chain Analysis
- 8.1.1 Pain Reliever Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pain Reliever Production Mode & Process
- 8.2 Pain Reliever Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pain Reliever Distributors
- 8.2.3 Pain Reliever Customers
9 Global Pain Reliever Analyzing Market Dynamics
- 9.1 Pain Reliever Industry Trends
- 9.2 Pain Reliever Industry Drivers
- 9.3 Pain Reliever Industry Opportunities and Challenges
- 9.4 Pain Reliever Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst